| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
V46205-1mg |
≥98% | ￥700.00 |
货期：3-5天 | - | - | - | - |
|
V46205-5mg |
≥98% | ￥1500.00 |
货期：3-5天 | - | - | - | - |
|
V46205-10mg |
≥98% | ￥2500.00 |
货期：3-5天 | - | - | - | - |
|
V46205-25mg |
≥98% | ￥4500.00 |
货期：3-5天 | - | - | - | - |
|
V46205-50mg |
≥98% | ￥7180.00 |
货期：3-5天 | - | - | - | - |
|
V46205-100mg |
≥98% | ￥11400.00 |
货期：3-5天 | - | - | - | - |
|
| 产品描述： | SPR741 (NAB741) is a cationic peptide derived from polymyxin B and is a potentiator molecule. SPR741 increases the permeability of the outer membrane of Gram-negative bacteria and is used to treat severe Gram-negative bacteria infections. SPR741 inhibits multidrug-resistant Gram-negative bacteria. The spectrum of activity of the antibiotic can be widened when used in combination with SPR741. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 体内研究： | SPR741 has the ability to permeabilize the outer membrane of Gram-negative bacteria, thus sensitizing them to hydrophobic antibiotics. SPR741 has a significantly safety profile of compared to that of polymyxin B, which suffers severe, dose-limiting nephro 웿 Ů ñ 샮㡽䇘睜⪰ޏࠃ 䇩睜 䇩睜Ȃ Ӥ 晐睦Ӥ 晐睦Ӥ 峀睜 弴睜 | ||||||||||||||||||||
| 参考文献： | 1. Corbett D, et al. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741. Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00200-17. 2. Eckburg PB, et al. Safety, Tolerability, Pharmacokineti 웿 Ů ñ 샮㡽䇘睜⪰ޏࠃ 䇩睜 䇩睜Ȃ Ӥ 晐睦Ӥ 晐睦Ӥ 峀睜 弴睜 ڤ 犐ƈ ڤ郥댻嬧睜Ӥ 乨Ƥ鄩댻婯睜Љ �ޝ乜Ƥ媜睜 Ӥ ItemҮ |
||||||||||||||||||||
| 保存条件： | -80°C, 干燥 | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京